Market news

Accuray (ARAY) stock surged 42% premarket following a strategic CyberKnife imaging partnership with Samsung NeuroLogica.

The agreements bring together mobile CT capabilities and precision treatment delivery expertise to improve anatomical visualisation during radiotherapy.

Accuray Inc.’s (NASDAQ:ARAY) recent agreement with RaySearch Laboratories around an extended alliance, is a major step toward online adaptive radiation therapy. The integration of Accuray’s imaging technology and photon-based radiation therapy platforms with RaySearch’s proprietary planning and workflow solutions, will fast-track innovation across the space. For Accuray, the arrangement will also accelerate its adoption to […]

On August 19, Accuray Incorporated (NASDAQ:ARAY) held its fiscal fourth-quarter and full-year 2026 earnings call, laying out a business caught between a genuine financial rescue and a China market that is still bleeding revenue. Total net revenue fell 21% in the quarter to $100.9 million, and the company won’t even offer a forecast for the […]

Motley Fool Press Release.

Tipranks Press Release.

Moby summary of Accuray Incorporated's Q4 2026 earnings call

Accuray: Fiscal Q4 Earnings Snapshot

Accuray (ARAY) reported a fiscal Q4 net loss late Wednesday of $0.02 per diluted share, swinging fro

Accuray exceeds cost-saving targets and strengthens balance sheet through TCW deal, despite revenue headwinds from China and tariff pressures.

Detailed price information for Accuray Inc (ARAY-Q) from The Globe and Mail including charting and trades.

Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter of fiscal year 2026, ended June 30, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on August 19, 2026.

Detailed price information for Accuray Inc (ARAY-Q) from The Globe and Mail including charting and trades.

Accuray (ARAY) said late Wednesday it has entered into definitive agreements with TCW Asset Manageme